{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:45:04Z","timestamp":1791852304735,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T00:00:00Z","timestamp":1251331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T00:00:00Z","timestamp":1251331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1038\/leu.2009.171","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T10:30:42Z","timestamp":1251369042000},"page":"2090-2101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells"],"prefix":"10.1038","volume":"23","author":[{"given":"H","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Iha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Tsukasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Atogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Tsuruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kamihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,27]]},"reference":[{"key":"BFleu2009171_CR1","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/sj.onc.1210263","volume":"26","author":"HF Horn","year":"2007","unstructured":"Horn HF, Vousden KH . Coping with stress: multiple ways to activate p53. Oncogene 2007; 26: 1306\u20131316.","journal-title":"Oncogene"},{"key":"BFleu2009171_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/jcb.21091","volume":"100","author":"ES Helton","year":"2007","unstructured":"Helton ES, Chen X . p53 modulation of the DNA damage response. J Cell Biochem 2007; 100: 883\u2013896.","journal-title":"J Cell Biochem"},{"key":"BFleu2009171_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.cdd.4401908","volume":"13","author":"JE Chipuk","year":"2006","unstructured":"Chipuk JE, Green DR . Dissecting p53-dependent apoptosis. Cell Death Differ 2006; 13: 994\u20131002.","journal-title":"Cell Death Differ"},{"key":"BFleu2009171_CR4","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/sj.cdd.4401910","volume":"13","author":"AJ Levine","year":"2006","unstructured":"Levine AJ, Hu W, Feng Z . The P53 pathway: what questions remain to be explored? Cell Death Differ 2006; 13: 1027\u20131036.","journal-title":"Cell Death Differ"},{"key":"BFleu2009171_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.bbrc.2005.03.189","volume":"331","author":"J Yu","year":"2005","unstructured":"Yu J, Zhang L . The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 2005; 331: 851\u2013858.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu2009171_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","volume":"126","author":"K Bensaad","year":"2006","unstructured":"Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126: 107\u2013120.","journal-title":"Cell"},{"key":"BFleu2009171_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1128\/MCB.26.2.502-512.2006","volume":"26","author":"M Sugimoto","year":"2006","unstructured":"Sugimoto M, Gromley A, Sherr CJ . Hzf, a p53-responsive gene, regulates maintenance of the G2 phase checkpoint induced by DNA damage. Mol Cell Biol 2006; 26: 502\u2013512.","journal-title":"Mol Cell Biol"},{"key":"BFleu2009171_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.cell.2007.06.013","volume":"130","author":"S Das","year":"2007","unstructured":"Das S, Raj L, Zhao B, Kimura Y, Bernstein A, Aaronson SA et al. Hzf determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell 2007; 130: 624\u2013637.","journal-title":"Cell"},{"key":"BFleu2009171_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","volume":"130","author":"M Collado","year":"2007","unstructured":"Collado M, Blasco MA, Serrano M . Cellular senescence in cancer and aging. Cell 2007; 130: 223\u2013233.","journal-title":"Cell"},{"key":"BFleu2009171_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cell.2006.10.003","volume":"127","author":"WY Kim","year":"2006","unstructured":"Kim WY, Sharpless NE . The regulation of INK4\/ARF in cancer and aging. Cell 2006; 127: 265\u2013275.","journal-title":"Cell"},{"key":"BFleu2009171_CR11","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1172\/JCI23437","volume":"114","author":"A Satyanarayana","year":"2004","unstructured":"Satyanarayana A, Rudolph KL . p16 and ARF: activation of teenage proteins in old age. J Clin Invest 2004; 114: 1237\u20131240.","journal-title":"J Clin Invest"},{"key":"BFleu2009171_CR12","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1038\/sj.onc.1208981","volume":"24","author":"M Yoshida","year":"2005","unstructured":"Yoshida M . Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 2005; 24: 5931\u20135937.","journal-title":"Oncogene"},{"key":"BFleu2009171_CR13","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1038\/sj.onc.1208979","volume":"24","author":"GP Taylor","year":"2005","unstructured":"Taylor GP, Matsuoka M . Natural history of adult T-cell leukemia\/lymphoma and approaches to therapy. Oncogene 2005; 24: 6047\u20136057.","journal-title":"Oncogene"},{"key":"BFleu2009171_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/1042819021000055039","volume":"44","author":"Y Yamada","year":"2003","unstructured":"Yamada Y, Tomonaga M . The current status of therapy for adult T-cell leukaemia-lymphoma in Japan. Leuk Lymphoma 2003; 44: 611\u2013618.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2009171_CR15","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1038\/sj.onc.1208978","volume":"24","author":"R Grassmann","year":"2005","unstructured":"Grassmann R, Aboud M, Jeang KT . Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005; 24: 5976\u20135985.","journal-title":"Oncogene"},{"key":"BFleu2009171_CR16","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1038\/sj.onc.1208976","volume":"24","author":"SJ Marriott","year":"2005","unstructured":"Marriott SJ, Semmes OJ . Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene 2005; 24: 5986\u20135995.","journal-title":"Oncogene"},{"key":"BFleu2009171_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0014-5793(97)00280-9","volume":"406","author":"T Akagi","year":"1997","unstructured":"Akagi T, Ono H, Tsuchida N, Shimotohno K . Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1. FEBS Lett 1997; 406: 263\u2013266.","journal-title":"FEBS Lett"},{"key":"BFleu2009171_CR18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/JVI.72.2.1165-1170.1998","volume":"72","author":"CA Pise-Masison","year":"1998","unstructured":"Pise-Masison CA, Choi KS, Radonovich M, Dittmer J, Kim SJ, Brady JN . Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J Virol 1998; 72: 1165\u20131170.","journal-title":"J Virol"},{"key":"BFleu2009171_CR19","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1128\/JVI.72.11.8852-8860.1998","volume":"72","author":"JC Mulloy","year":"1998","unstructured":"Mulloy JC, Kislyakova T, Cereseto A, Casareto L, LoMonico A, Fullen J et al. Human T-cell lymphotropic\/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB\/ATF functional domain. J Virol 1998; 72: 8852\u20138860.","journal-title":"J Virol"},{"key":"BFleu2009171_CR20","doi-asserted-by":"publisher","first-page":"9346","DOI":"10.1128\/JVI.79.14.9346-9350.2005","volume":"79","author":"A Miyazato","year":"2005","unstructured":"Miyazato A, Sheleg S, Iha H, Li Y, Jeang KT . Evidence for NF-kappaB- and CBP-independent repression of p53\u2032s transcriptional activity by human T-cell leukemia virus type 1 Tax in mouse embryo and primary human fibroblasts. J Virol 2005; 79: 9346\u20139350.","journal-title":"J Virol"},{"key":"BFleu2009171_CR21","first-page":"283","volume":"53","author":"CA Pise-Masison","year":"2005","unstructured":"Pise-Masison CA, Jeong SJ, Brady JN . Human T cell leukemia virus type 1: the role of Tax in leukemogenesis. Arch Immunol Ther Exp (Warsz) 2005; 53: 283\u2013296.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"BFleu2009171_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ccr.2007.10.001","volume":"12","author":"T Soussi","year":"2007","unstructured":"Soussi T, Wiman KG . Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 2007; 12: 303\u2013312.","journal-title":"Cancer Cell"},{"key":"BFleu2009171_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1126\/science.1092472","volume":"303","author":"LT Vassilev","year":"2004","unstructured":"Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004; 303: 844\u2013848.","journal-title":"Science"},{"key":"BFleu2009171_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molmed.2006.11.002","volume":"13","author":"LT Vassilev","year":"2007","unstructured":"Vassilev LT . MDM2 inhibitors for cancer therapy. Trends Mol Med 2007; 13: 23\u201331.","journal-title":"Trends Mol Med"},{"key":"BFleu2009171_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.canlet.2005.03.039","volume":"234","author":"M Tawara","year":"2006","unstructured":"Tawara M, Hogerzeil SJ, Yamada Y, Takasaki Y, Soda H, Hasegawa H et al. Impact of p53 aberration on the progression of adult T-cell leukemia\/lymphoma. Cancer Lett 2006; 234: 249\u2013255.","journal-title":"Cancer Lett"},{"key":"BFleu2009171_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2141.2004.05289.x","volume":"128","author":"H Hasegawa","year":"2005","unstructured":"Hasegawa H, Yamada Y, Harasawa H, Tsuji T, Murata K, Sugahara K et al. Sensitivity of adult T-cell leukaemia lymphoma cells to tumour necrosis factor-related apoptosis-inducing ligand. Br J Haematol 2005; 128: 253\u2013265.","journal-title":"Br J Haematol"},{"key":"BFleu2009171_CR27","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","volume":"79","author":"M Yoshida","year":"1982","unstructured":"Yoshida M, Miyoshi I, Hinuma Y . Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031\u20132035.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009171_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1084\/jem.154.2.333","volume":"154","author":"LE Posner","year":"1981","unstructured":"Posner LE, Robert-Guroff M, Kalyanaraman VS, Poiesz BJ, Ruscetti FW, Fossieck B et al. Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas. J Exp Med 1981; 154: 333\u2013346.","journal-title":"J Exp Med"},{"key":"BFleu2009171_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1742-4690-5-34","volume":"5","author":"T Usui","year":"2008","unstructured":"Usui T, Yanagihara K, Tsukasaki K, Murata K, Hasegawa H, Yamada Y et al. Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells. Retrovirology 2008; 5: 34.","journal-title":"Retrovirology"},{"key":"BFleu2009171_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","volume":"137","author":"MC Berenbaum","year":"1978","unstructured":"Berenbaum MC . A method for testing for synergy with any number of agents. J Infect Dis 1978; 137: 122\u2013130.","journal-title":"J Infect Dis"},{"key":"BFleu2009171_CR31","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1182\/blood-2007-01-068981","volume":"110","author":"H Hasegawa","year":"2007","unstructured":"Hasegawa H, Yamada Y, Komiyama K, Hayashi M, Ishibashi M, Sunazuka T et al. A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production. Blood 2007; 110: 1664\u20131674.","journal-title":"Blood"},{"key":"BFleu2009171_CR32","doi-asserted-by":"publisher","first-page":"8912","DOI":"10.1038\/sj.onc.1207058","volume":"22","author":"H Iha","year":"2003","unstructured":"Iha H, Kibler KV, Yedavalli VR, Peloponese JM, Haller K, Miyazato A et al. Segregation of NF-kappaB activation through NEMO\/IKKgamma by Tax and TNFalpha: implications for stimulus-specific interruption of oncogenic signaling. Oncogene 2003; 22: 8912\u20138923.","journal-title":"Oncogene"},{"key":"BFleu2009171_CR33","first-page":"3029","volume":"8","author":"RL Reid","year":"1993","unstructured":"Reid RL, Lindholm PF, Mireskandari A, Dittmer J, Brady JN . Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene 1993; 8: 3029\u20133036.","journal-title":"Oncogene"},{"key":"BFleu2009171_CR34","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.1128\/MCB.10.10.5502","volume":"10","author":"J Cheng","year":"1990","unstructured":"Cheng J, Haas M . Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 1990; 10: 5502\u20135509.","journal-title":"Mol Cell Biol"},{"key":"BFleu2009171_CR35","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/ijc.2910490614","volume":"49","author":"S Sugito","year":"1991","unstructured":"Sugito S, Yamato K, Sameshima Y, Yokota J, Yano S, Miyoshi I . Adult T-cell leukemia: structures and expression of the p53 gene. Int J Cancer 1991; 49: 880\u2013885.","journal-title":"Int J Cancer"},{"key":"BFleu2009171_CR36","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","volume":"88","author":"G Gaidano","year":"1991","unstructured":"Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88: 5413\u20135417.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009171_CR37","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1182\/blood.V79.9.2378.2378","volume":"79","author":"K Sugimoto","year":"1992","unstructured":"Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Ishikawa F et al. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. blood 1992; 79: 2378\u20132383.","journal-title":"blood"},{"key":"BFleu2009171_CR38","first-page":"593","volume":"7","author":"A Neubauer","year":"1993","unstructured":"Neubauer A, He M, Schmidt CA, Huhn D, Liu ET . Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques. Leukemia 1993; 7: 593\u2013600.","journal-title":"Leukemia"},{"key":"BFleu2009171_CR39","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1182\/blood.V95.12.3939.012k30_3939_3944","volume":"95","author":"S Takemoto","year":"2000","unstructured":"Takemoto S, Trovato R, Cereseto A, Nicot C, Kislyakova T, Casareto L et al. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia\/lymphoma cells. Blood 2000; 95: 3939\u20133944.","journal-title":"Blood"},{"key":"BFleu2009171_CR40","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood.V88.5.1551.1551","volume":"88","author":"A Cereseto","year":"1996","unstructured":"Cereseto A, Diella F, Mulloy JC, Cara A, Michieli P, Grassmann R et al. p53 functional impairment and high p21waf1\/cip1 expression in human T-cell lymphotropic\/leukemia virus type I-transformed T cells. Blood 1996; 88: 1551\u20131560.","journal-title":"Blood"},{"key":"BFleu2009171_CR41","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1182\/blood-2005-02-0553","volume":"106","author":"K Kojima","year":"2005","unstructured":"Kojima K, Konopleva M, Samudio IJ, Shikami M, Cabreira-Hansen M, McQueen T et al. MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy. Blood 2005; 106: 3150\u20133159.","journal-title":"Blood"},{"key":"BFleu2009171_CR42","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1182\/blood-2005-08-3273","volume":"107","author":"L Coll-Mulet","year":"2006","unstructured":"Coll-Mulet L, Iglesias-Serret D, Santidri\u00e1n AF, Cosialls AM, de Frias M, Casta\u00f1o E et al. MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells. Blood 2006; 107: 4109\u20134114.","journal-title":"Blood"},{"key":"BFleu2009171_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1182\/blood-2005-05-1982","volume":"107","author":"H Hasegawa","year":"2006","unstructured":"Hasegawa H, Yamada Y, Komiyama K, Hayashi M, Ishibashi M, Yoshida T et al. Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells. Blood 2006; 107: 679\u2013688.","journal-title":"Blood"},{"key":"BFleu2009171_CR44","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.cell.2006.12.007","volume":"127","author":"CP Martins","year":"2006","unstructured":"Martins CP, Brown-Swigart L, Evan GI . Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 2006; 127: 1323\u20131334.","journal-title":"Cell"},{"key":"BFleu2009171_CR45","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445: 656\u2013660.","journal-title":"Nature"},{"key":"BFleu2009171_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05541","volume":"445","author":"A Ventura","year":"2007","unstructured":"Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445: 661\u2013665.","journal-title":"Nature"},{"key":"BFleu2009171_CR47","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1073\/pnas.0507493103","volume":"103","author":"C Tovar","year":"2006","unstructured":"Tovar C, Rosinski J, Filipovic Z, Higgins B, Kolinsky K, Hilton H et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci USA 2006; 103: 1888\u20131893.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009171_CR48","doi-asserted-by":"publisher","first-page":"9646","DOI":"10.1158\/0008-5472.CAN-06-0792","volume":"66","author":"T Van Maerken","year":"2006","unstructured":"Van Maerken T, Speleman F, Vermeulen J, Lambertz I, De Clercq S, De Smet E et al. Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma. Cancer Res 2006; 66: 9646\u20139655.","journal-title":"Cancer Res"},{"key":"BFleu2009171_CR49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrc1954","volume":"6","author":"CJ Sherr","year":"2006","unstructured":"Sherr CJ . Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 2006; 6: 663\u2013673.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2009171_CR50","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/436642a","volume":"436","author":"M Collado","year":"2005","unstructured":"Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436: 642.","journal-title":"Nature"},{"key":"BFleu2009171_CR51","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2006-01-0067","volume":"108","author":"A Datta","year":"2006","unstructured":"Datta A, Bellon M, Sinha-Datta U, Bazarbachi A, Lepelletier Y, Canioni D et al. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood 2006; 108: 1021\u20131029.","journal-title":"Blood"},{"key":"BFleu2009171_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1128\/JVI.01497-07","volume":"82","author":"A Dasgupta","year":"2008","unstructured":"Dasgupta A, Jung KJ, Jeong SJ, Brady JN . Inhibition of methyltransferases results in induction of G2\/M checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells. J Virol 2008; 82: 49\u201359.","journal-title":"J Virol"},{"key":"BFleu2009171_CR53","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.virol.2007.09.003","volume":"370","author":"SJ Jeong","year":"2008","unstructured":"Jeong SJ, Dasgupta A, Jung KJ, Um JH, Burke A, Park HU et al. PI3K\/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells. Virology 2008; 370: 264\u2013272.","journal-title":"Virology"},{"key":"BFleu2009171_CR54","doi-asserted-by":"publisher","first-page":"8537","DOI":"10.1128\/JVI.00690-08","volume":"82","author":"KJ Jung","year":"2008","unstructured":"Jung KJ, Dasgupta A, Huang K, Jeong SJ, Pise-Masison C, Gurova KV et al. Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells. J Virol 2008; 82: 8537\u20138547.","journal-title":"J Virol"},{"key":"BFleu2009171_CR55","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1038\/sj.emboj.7601054","volume":"25","author":"YL Kuo","year":"2006","unstructured":"Kuo YL, Giam CZ . Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence. EMBO J 2006; 25: 1741\u20131752.","journal-title":"EMBO J"},{"key":"BFleu2009171_CR56","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2006.10.010","volume":"10","author":"I Ringshausen","year":"2006","unstructured":"Ringshausen I, O\u2032Shea CC, Finch AJ, Swigart LB, Evan GI . Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo. Cancer Cell 2006; 10: 501\u2013514.","journal-title":"Cancer Cell"},{"key":"BFleu2009171_CR57","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.ejca.2006.03.018","volume":"42","author":"EW Duiker","year":"2006","unstructured":"Duiker EW, Mom CH, de Jong S, Willemse PH, Gietema JA, van der Zee AG et al. The clinical trail of TRAIL. Eur J Cancer 2006; 42: 2233\u20132240.","journal-title":"Eur J Cancer"},{"key":"BFleu2009171_CR58","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.2741\/2354","volume":"12","author":"U Schaefer","year":"2007","unstructured":"Schaefer U, Voloshanenko O, Willen D, Walczak H . TRAIL: a multifunctional cytokine. Front Biosci 2007; 12: 3813\u20133824.","journal-title":"Front Biosci"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2009171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009171","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:27:55Z","timestamp":1648729675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2009171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,27]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["BFleu2009171"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.171","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,27]]},"assertion":[{"value":"12 May 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}